Search





Search





Markets
/
Stocks
/
akts
/

Akoustis Technologies Ord Shs

AKTS

Add to Watchlist

24.010USD

-0.800-3.22%

Close 07-23 16:00（ET）Quotes delayed by 15 min

1.22BMarket Cap

LossP/E TTM

Akoustis Technologies Ord Shs

24.010

-0.800-3.22%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

-3.22%

5 Days

-4.04%

1 Month

-11.11%

6 Months

+10.90%

Year to Date

0.00%

1 Year

0.00%

Key Figures

24.350Open

24.685High

298.71KVolume

LossP/E TTM

LossP/E Dynamic

--Dividend TTM

0.59%Turnover Ratio

24.810Prev. Close

23.600Low

5.04MTurnover

LossP/E Static

-9.19P/B

0.00%Div Yield TTM

-167.18%ROA

29.16052wk High

1.16Volume Ratio

-167.95MNet Profit

50.65MShares

-1.3392EPS TTM

--Beta

-11970.59%ROE

14.72052wk Low

4.37%Amplitude

100.00%Gross Margin

1.22BMarket Cap

-2.93Reward/Risk

4.63%Risk Rate

TradingKey Stock Score of Akoustis Technologies Ord Shs

Currency: USD Updated: 2026-07-23

Key Insights

Akoustis Technologies Ord Shs's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 4 out of 12 in the Investment Holding Companies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 35.50.In the medium term, the stock price is expected to trend up.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Akoustis Technologies Ord Shs's Score

Industry at a Glance

Industry Ranking

4 / 12

Overall Ranking

276 / 4547

Industry

Investment Holding Companies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive+

Akoustis Technologies Ord Shs Highlights

StrengthsRisks

Aktis Oncology Inc is a United States-based biotechnology company. The Company focuses on developing targeted radiopharmaceuticals for treating solid tumor cancers. It also aims to deliver high doses of radiation directly to tumors, minimizing harm to healthy tissue. It transforms cancer care with novel platform technologies that enables to design and develop precision for radiopharmaceuticals. Its drugs are designed to bind to specific proteins on cancer cells, delivering radiation directly to the tumor.

Growing

The company is in a growing phase, with the latest annual income totaling USD 6.50M.

Fairly Valued

The company’s latest PE is -17.93, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 27.52M shares, increasing 3.93% quarter-over-quarter.

Held by Bill Nygren | OAKMX

Star Investor Bill Nygren | OAKMX holds 13.75K shares of this stock.

Analyst Rating

Based on 7 analysts

Strong Buy

Current Rating

35.500

Target Price

+44.13%

Upside Space

Akoustis Technologies Ord Shs News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 7 analysts

Strong Buy

Current Rating

35.500

Target Price

+44.13%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Akoustis Technologies Ord Shs

AKTS

SUNB.NB

SUNB

Bobs Discount Furniture Ord Shs

BOBS

Compass Diversified Holdings

CODI

Cannae Holdings Inc

CNNE

Virtuix Holdings Ord Shs (Unlisted)

VTIX

Indicators

Indicators

Sell(2)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-1.380

Neutral

RSI(14)

44.786

Neutral

STOCH(KDJ)(9,3,3)

16.221

Oversold

ATR(14)

2.239

Low Volatility

CCI(14)

-94.452

Neutral

Williams %R

94.470

Oversold

TRIX(12,20)

0.105

Sell

StochRSI(14)

13.540

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

24.460

Sell

MA10

25.195

Sell

MA20

27.439

Sell

MA50

23.432

Buy

MA100

21.100

Buy

MA200

20.783

Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Akoustis Technologies Ord Shs Info

Ticker SymbolAKTS

CompanyAkoustis Technologies Ord Shs

CEORoden (Matthew)

Websitehttps://www.aktisoncology.com/

Shareholders

Shareholders

Proportion

MPM BioImpact LLC

19.21%

Eli Lilly and Company

11.88%

VV Manager LLC

10.92%

EcoR1 Capital, LLC

9.03%

Wellington Management Company, LLP

4.17%

Other

44.79%

Related Instruments

Bobs Discount Furniture Ord Shs



-5.39%

Perceptive Capital Solutions Corp



0.00%

JATT II Acquisition Ord Shs



-3.19%

Churchill Capital XI Units



-1.43%

Compass Diversified Holdings

Drugs Made In America Acquisition II Ord Shs

Cantor Equity Partners IV Ord Shs Class A



-0.25%

Bain Capital GSS Investment Ord Shs Class A



+0.20%

American Exceptionalism Acquisition Ord Shs Class A



-0.26%

EQV Ventures Acquisition Ord Shs Class A



-0.25%

Rice Acquisition 3 Ord Shs Class A



+0.57%

Agriculture & Natural Solutions Acquisition Corp

Apex Treasury Ord Shs Class A

Popular Instruments

FAQs

What is the current price of Akoustis Technologies Ord Shs (AKTS)?



The current price of Akoustis Technologies Ord Shs (AKTS) is 24.01.

What is the symbol of Akoustis Technologies Ord Shs?



The ticker symbol of Akoustis Technologies Ord Shs is AKTS.

What is the 52-week high of Akoustis Technologies Ord Shs?



The 52-week high of Akoustis Technologies Ord Shs is 29.16.

What is the 52-week low of Akoustis Technologies Ord Shs?



The 52-week low of Akoustis Technologies Ord Shs is 14.72.

What is the market capitalization of Akoustis Technologies Ord Shs?



The market capitalization of Akoustis Technologies Ord Shs is 1.22B.

Is Akoustis Technologies Ord Shs (AKTS) currently rated as Buy, Hold, or Sell?



According to analysts, Akoustis Technologies Ord Shs (AKTS) has an overall rating of STRONG BUY, with a price target of 35.50.

What is the Earnings Per Share (EPS TTM) of Akoustis Technologies Ord Shs (AKTS)?



The Earnings Per Share (EPS TTM) of Akoustis Technologies Ord Shs (AKTS) is -1.26.